JP Morgan Chase’s Flexion Therapeutics, Inc. FLXN Stock Holding History

JP Morgan Chase’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-830,546	Closed	-$5.07M	–	7303
2021 Q3	$5.07M	Buy	830,546 +96,380	+13%	+$601K	﹤0.01%	3010
2021 Q2	$6.04M	Buy	734,166 +8,012	+1%	+$68.1K	﹤0.01%	2891
2021 Q1	$6.5M	Buy	726,154 +189,553	+35%	+$2.17M	﹤0.01%	2762
2020 Q4	$6.19M	Buy	536,601 +122,814	+30%	+$1.43M	﹤0.01%	2621
2020 Q3	$4.3M	Buy	413,787 +15,121	+4%	+$185K	﹤0.01%	2696
2020 Q2	$5.24M	Buy	398,666 +223,754	+128%	+$2.32M	﹤0.01%	2417
2020 Q1	$1.38M	Buy	174,912 +26,763	+18%	+$403K	﹤0.01%	3214
2019 Q4	$3.07M	Buy	148,149 +13,976	+10%	+$236K	﹤0.01%	3073
2019 Q3	$1.84M	Buy	134,173 +6,595	+5%	+$78.3K	﹤0.01%	3482
2019 Q2	$1.5M	Sell	127,578 -7,916	-6%	-$91.3K	﹤0.01%	3566
2019 Q1	$1.69M	Sell	135,494 -8,785	-6%	-$117K	﹤0.01%	3447
2018 Q4	$1.63M	Sell	144,279 -8,076	-5%	-$127K	﹤0.01%	3421
2018 Q3	$2.85M	Buy	152,355 +9,460	+7%	+$217K	﹤0.01%	3200
2018 Q2	$3.69M	Sell	142,895 -8,502	-6%	-$221K	﹤0.01%	2929
2018 Q1	$3.39M	Sell	151,397 -14,774	-9%	-$361K	﹤0.01%	2891
2017 Q4	$4.16M	Buy	166,171 +1,771	+1%	+$43.4K	﹤0.01%	2826
2017 Q3	$3.93M	Sell	164,400 -2,950	-2%	-$69.3K	﹤0.01%	2736
2017 Q2	$3.38M	Buy	167,350 +52,763	+46%	+$1.1M	﹤0.01%	2734
2017 Q1	$3.08M	Sell	114,587 -11,235	-9%	-$229K	﹤0.01%	2767
2016 Q4	$2.39M	Buy	125,822 +6,772	+6%	+$129K	﹤0.01%	2952
2016 Q3	$2.33M	Buy	119,050 +7,075	+6%	+$120K	﹤0.01%	2704
2016 Q2	$1.68M	Sell	111,975 -6,025	-5%	-$75.7K	﹤0.01%	2906
2016 Q1	$1.09M	Buy	118,000 +4,645	+4%	+$56.3K	﹤0.01%	3033
2015 Q4	$2.18M	Buy	+113,355	New	+$1.97M	﹤0.01%	2710
2014 Q3	–	Sell	-271,676	Closed	-$3.66M	–	4305
2014 Q2	$3.66M	Sell	271,676 -56,399	-17%	-$769K	﹤0.01%	2233
2014 Q1	$5.4M	Buy	+328,075	New	+$5.67M	﹤0.01%	2038